Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
ACQUIRED COMPANY
 
My Lists

Iconix Biosciences  Acquired by Entelos (2007 $ 8,300,000 )

325 E. Middlefield Road
Mountain View, CA 94043
USA
(650)-567-5500
Website Company Summary Management Team
Company

Business description: Iconix Biosciences Inc. is pioneering the new field of chemogenomics, the integration of chemistry and genomics to profile drug candidates. Iconix’s chemogenomic capabilities enable pharmaceutical companies to increase the odds of advancing the right compounds to the clinic, reducing attrition rates and the costs of drug discovery. Iconix Biosciences is among the first of its kind: a multi-disciplinary company that integrates the laboratory skills and knowledge necessary for the creation of the world’s largest chemogenomics database of microarray and pharmacology data with the informatics expertise and computer skills required to mine and interpret this vast body of information. Iconix’s chemogenomics platform includes an integrated database architecture to bridge genomics and drug design, novel bio- and chemoinformatics software, and advanced expression array and cellular assay development capabilities. Iconix has focused these technologies on a line of chemogenomics products, services, and long-term collaborations.
Customers include: Millennium Pharmaceuticals
Partners include: Affymetrix AstraZenecaBristol-Myers SquibbCymaBay TherapeuticsEli Lilly IncyteMicrocide Pharmaceuticals;  Eisai;  ICOS;  MDS Pharma Services;  Rosetta Biosoftware ;  Schering-Plough Research Institute;  Taisho Pharmaceutical
Capital

Rounds: 2
Recent Fundings: Dec 2006   Jan 2004
Capital raised: 62.5M
Last Round: 6.0M
Ownership: Acquired by Entelos (2007 $ 8,300,000 )

Last Tweets


 

Last Mentions


Overview
Record updated: Dec 2008
Sector: Biotech
Year Founded: 1998
Headcount: 26-50 as of Mar 2005
Rounds: 2
Recent Fundings: Dec 2006   Jan 2004
Capital Raised: 62.5M
Last Round: 6.0M
Ownership: Acquired by Entelos (2007 $ 8,300,000 )